You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
NOVEL ADENOSINE A2A AGONISTS IN RENAL TISSUE PROTECTION
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): The development of new treatments for the effective reduction of renal injury associated with acute renal failure and kidney transplantation will have a great impact on health care delivery to patients with renal disease. Acute ischemic renal failure affects 5 percent of hospitalized patients and has a mortality rate approaching 50 percent. At present, dialysis ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
A2A ADENOSINE AGONISTS LIMIT DAMAGE FROM INFECTION
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/Aepsis syndrome is the 11th leading cause of death in the United States ( about 900,000 new cases per year) with a mortality of about 35 percent. The need for adjunctive therapies is urgent. In Phase I of this SBIR award we documented the anti-inflammatory effects of adenosine A2A receptor (A2AAR) agonists on isolated immune cells and have observed ramatically improved survival in mouse models of I ...
STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
A2A ADENOSINE AGONISTS AS NEUROPROTECTANTS
SBC: ADENOSINE THERAPEUTICS, LLC Topic: N/ADESCRIPTION (provided by applicant): The central goal of this research is to develop a new drug to prevent spinal cord reperfusion injury secondary to aortic clamping that occurs frequently during thoracic surgery. Irreversible spinal cord injury resulting in paraplegia or paraparesis is the single most devastating complication of surgery on the thoracic and thor ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
ACCUNURSE SYSTEM
SBC: Adherence Technologies Corp. Topic: N/ADESCRIPTION (provided by applicant): The AccuNurse System has been successfully developed in Phase I to provide an easy-to-use "mentor" and communications tool for CNAs and nurses in skilled nursing units. Wireless and advanced speech technologies are merged into a conversational system that provides: individualized resident information, paperless documentation at the point of care, and many other ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
ACTIVITIES OF DAILY LIVING ENHANCEMENT PERFORMANCE TOOL
SBC: CARLOW INTERNATIONAL, INC. Topic: N/ADESCRIPTION (provided by applicant): The overall goal of the ADEPT project is to enhance the independence, autonomy, safety, and performance of patients with dementia in conducting activities of daily living (ADL). The overall objective of ADEPT development is to enhance patient care in Special Care Units (SCUs) through the further development and testing of a computerized, self-directed, traini ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF IMPROVED PEDIATRIC SPACER FOR INHALERS
SBC: CFD RESEARCH CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Over 50 % of drug leaving a metered dose inhaler (MDI) never reaches the patient and instead is deposited with in the pacer. There is also a very high degree of dependence of drug delivery on the combination of drug/spacer/patient factors. Detailed understanding drug delivery. The overall goal of the proposed study is to design, fabricate and test an improved p ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF A SKIN FLAP THERAPY DEVICE
SBC: COTTLER TECHNOLOGIES, LLC Topic: N/ADESCRIPTION (provided by applicant): Research done prior to and including Phase I has led to publications and subsequent data that has proven the feasibility of utilizing a self-contained device as the standard of care in removing stagnated blood and generation of blood flow within congested skin flaps to promote survival. Completion of Phase I was the development of the AspiraideTM, a device that ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
WEARABLE PROGRAMMABLE TACTILE SPEECH AID FOR DEAF PEOPLE
SBC: COULTER ASSOCIATES, INC. Topic: N/ADESCRIPTION (provided by applicant): The Phase II program has two key aspects: Coulter Associates will build on its successful SBIR Phase I wristwatch device to develop an innovative and even more highly miniaturized tactile device specifically for infants. This device will provide vibrotactile stimulation on the infant's forearm to create an awareness of their acoustic and speech environment. Th ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
Simple Device/Measure Omnidirectional Germicidal UV Rad
SBC: RIVERBEND INSTRUMENTS, INC. Topic: N/AN/A
SBIR Phase II 2002 Department of Health and Human ServicesCenters for Disease Control and Prevention -
PHYTOFILTRATION OF ARSENIC-CONTAMINATED DRINKING WATER
SBC: Edenspace Systems Corporation Topic: N/ADESCRIPTION (provided by applicant): Arsenic contamination of drinking water poses significant health risks to millions of people worldwide. Current technologies used to clean arsenic-contaminated water have significant drawbacks, such as high cost and generation of large volumes of toxic waste. Edenspace Systems Corporation proposes to create the basis for a cost-effective phytofiltration techno ...
SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health